Literature DB >> 9497180

Effects of L-carnitine on erythrocyte acyl-CoA, free CoA, and glycerophospholipid acyltransferase in uremia.

B de los Reyes1, J A Navarro, R Pérez-García, A Liras, Y Campos, B Bornstein, J Arenas.   

Abstract

We studied the effects of L-carnitine treatment in the acyl flux of erythrocyte membranes from uremic patients. We found a significantly lower relative proportion of long-chain acyl-CoA (LCCoA) to free CoA (FCoA) in patients than in control subjects. In addition, patients had reduced activities of both carnitine palmitoyltransferase (CPT) and glycerophospholipid acyltransferase (LAT; CoA dependent), and increased ratios of long-chain acylcarnitine (LCAC) to free carnitine in their erythrocytes. These data support the hypothesis that acyl-trafficking is altered in erythrocytes in uremia. After treatment with L-carnitine, we observed a significant increase in CPT and LAT activities as well as in the LCCoA-FCoA ratio, and a significant decrease in the ratio of LCAC to free carnitine. These results support the conclusion that L-carnitine supplementation improves erythrocyte flux in uremic patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9497180     DOI: 10.1093/ajcn/67.3.386

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  3 in total

1.  Carnitine supplementation improves cardiac strain rate in children on chronic hemodialysis.

Authors:  Kristen Sgambat; Lowell Frank; Ahmad Ellini; Craig Sable; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2012-03-22       Impact factor: 3.714

Review 2.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

3.  Comparison of vitamin e and L-carnitine, separately or in combination in patients with intradialytic complications.

Authors:  Hamid Tayebi Khosroshahi; Bohlul Habibi Asl; Afshin Habibzadeh; Parastoo Chaichi; Amin Ghanbarpour; Amir Hossein Badie
Journal:  Nephrourol Mon       Date:  2013-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.